| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |